Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

In one of them, SCORAD was not compared directly between groups, and the product also contained gamma-linolenic acid and vitamin D₃ (9).

Source: Narrative synthesis of findings. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Systematic review.

Systematic review

Uses explicit methods to identify, assess and summarise research on a defined question.

Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Prenatal and postnatal omega-3 supplementation for the prevention and treatment of atopic dermatitis: a systematic review of randomized controlled trials

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Prenatal and postnatal omega-3 supplementation for the prevention and treatment of atopic dermatitis: a systematic review of randomized controlled trials

Systematic review · Frontiers in Allergy · 2026

Original publication title

Prenatal and postnatal omega-3 supplementation for the prevention and treatment of atopic dermatitis: a systematic review of randomized controlled trials

Leen M. Aljabri; Hams D. Alzahrani; Fatimah O. Sulaymani; Futun F. Sulaimani; Amal A. Alzahrani; Norah G. Nahhas

© 2026 Aljabri, Alzahrani, Sulaymani, Sulaimani, Alzahrani and Nahhas.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Randomized controlled trial evidence does not support omega-3 supplementation for the prevention of AD, whether given prenatally or postnatally. Limited evidence suggests a possible benefit in children with established AD, which should be tested in larger trials. Any role of fatty acid composition or maternal genotype remains hypothesis-generating.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

To systematically review and narratively synthesize randomized controlled trial evidence on prenatal and postnatal omega-3 fatty acid supplementation for the prevention and treatment of AD in infants and children.

Source: Objective

Abstract: What methods does the paper describe?

PubMed and Web of Science were searched in October 2025, with an updated PubMed search in October 2026, to identify randomized controlled trials of omega-3 supplementation given during pregnancy or after birth that reported AD outcomes. Data were extracted, and risk of bias was assessed using RoB 2. Trials were grouped by clinical indication (prevention or treatment) and timing of supplementation, and a narrative synthesis was performed because of substantial heterogeneity.

Source: Methods

Abstract: Systematic Review Registration

PROSPERO CRD420251161453.

Source: Systematic Review Registration

Abstract: Results

Eleven randomized controlled trials were included: nine prevention trials (six prenatal and three postnatal) and two treatment trials in children with established AD. Prenatal supplementation did not show a consistent preventive effect. Lower IgE-associated eczema was reported in two trials in high-risk families, but the effect was not always significant after adjustment and did not persist at longer follow-up; the two most recent trials found no overall effect, and one trial reported more eczema with omega-3. In one trial, the effect differed by maternal PTGS1 (COX-1) genotype.

None of the three postnatal prevention trials found a significant effect. Both treatment trials reported improvement in AD severity, but they were small and short, and one used a multi-component product. Risk of bias was low in one trial, raised some concerns in seven, and was high in three.

Source: Results

Abstract: Conclusions

Randomized controlled trial evidence does not support omega-3 supplementation for the prevention of AD, whether given prenatally or postnatally. Limited evidence suggests a possible benefit in children with established AD, which should be tested in larger trials. Any role of fatty acid composition or maternal genotype remains hypothesis-generating.

Source: Conclusions
Authors’ abstract

Background

Atopic dermatitis (AD) is a prevalent chronic inflammatory skin disease of childhood. Omega-3 fatty acids have been investigated for their potential role in modulating allergic inflammation; however, evidence regarding their effectiveness in preventing or treating AD remains inconsistent.

Objective

To systematically review and narratively synthesize randomized controlled trial evidence on prenatal and postnatal omega-3 fatty acid supplementation for the prevention and treatment of AD in infants and children.

Methods

PubMed and Web of Science were searched in October 2025, with an updated PubMed search in October 2026, to identify randomized controlled trials of omega-3 supplementation given during pregnancy or after birth that reported AD outcomes. Data were extracted, and risk of bias was assessed using RoB 2. Trials were grouped by clinical indication (prevention or treatment) and timing of supplementation, and a narrative synthesis was performed because of substantial heterogeneity.

Results

Eleven randomized controlled trials were included: nine prevention trials (six prenatal and three postnatal) and two treatment trials in children with established AD. Prenatal supplementation did not show a consistent preventive effect. Lower IgE-associated eczema was reported in two trials in high-risk families, but the effect was not always significant after adjustment and did not persist at longer follow-up; the two most recent trials found no overall effect, and one trial reported more eczema with omega-3. In one trial, the effect differed by maternal PTGS1 (COX-1) genotype.

None of the three postnatal prevention trials found a significant effect. Both treatment trials reported improvement in AD severity, but they were small and short, and one used a multi-component product. Risk of bias was low in one trial, raised some concerns in seven, and was high in three.

Conclusions

Randomized controlled trial evidence does not support omega-3 supplementation for the prevention of AD, whether given prenatally or postnatally. Limited evidence suggests a possible benefit in children with established AD, which should be tested in larger trials. Any role of fatty acid composition or maternal genotype remains hypothesis-generating.

Systematic Review Registration

PROSPERO CRD420251161453.

Publication and source details

Original title: Prenatal and postnatal omega-3 supplementation for the prevention and treatment of atopic dermatitis: a systematic review of randomized controlled trials

Leen M. Aljabri; Hams D. Alzahrani; Fatimah O. Sulaymani; Futun F. Sulaimani; Amal A. Alzahrani; Norah G. Nahhas

Frontiers in Allergy · 2026

* Correspondence: Leen M. Aljabri leenaljabriii@gmail.com © 2026 Aljabri, Alzahrani, Sulaymani, Sulaimani, Alzahrani and Nahhas. 2026Aljabri, Alzahrani, Sulaymani, Sulaimani, Alzahrani and Nahhashttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. The author(s) declared that financial support was not received for this work and/or its publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T10:23:37.717238+00:00

DOI: 10.3389/falgy.2026.1963461 ·